Intermittent preventive treatment with sulphadoxine-pyrimethamine ( IPTp-SP ) is being implemented in most malaria endemic countries as a standard two-doses regimen as it reduces the risk of low birth weight ( LBW ) and the prevalence of maternal anaemia .